Class Action Lawsuits Now Target More Than a Dozen Law Schools
NEWARK, N.J., Feb. 6, 2012 /PRNewswire/ -- A threatened wave of class actions against American law schools became a reality last week after plaintiffs' lawyers sued a dozen more schools over their allegedly ...
BofA investor lawsuit wins class-action status
Investors suing Bank of America Corp won class-action status for their lawsuit accusing the bank of fraudulently misleading them about the 2008 takeover of Merrill Lynch & Co and the size of Merrill's ...
Class-Action Suit Against Goldman
Last week, the federal judge in Manhattan ordered The Goldman Sachs Group Inc. to deal with a securities class-action lawsuit. The lawsuit accused Goldman of misleading investors relating to mortgage-backed ...
Carlyle Drops Class-Action Lawsuit Ban as Opposition Mounts
Carlyle Group LP abandoned a plan to ban shareholders from filing class-action lawsuits after U.S. regulators threatened to block a stock sale the private-equity firm is seeking to complete as soon as April.
Five lawsuits filed against Hecla
Five class-action lawsuits were filed against Hecla Mining Company this week.
Class-Action Suit Against Goldman - Analyst Blog
Last week, the federal judge in Manhattan ordered The Goldman Sachs Group Inc. ( GS ) to deal with a securities class-action lawsuit. The lawsuit accused Goldman of misleading
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc.
Shareholder rights firm Robbins Umeda LLP, announces that the firm commenced a class action lawsuit on February 3, 2012 in the U.S. District Court for the Northern District of Illinois, Eastern Division, on behalf of all persons or entities who purchased or otherwise acquired the securities of BioSante Pharmaceuticals, Inc.
Class-action lawyers swarm around buyout deals
Most merger litigation is pretty weak, Columbia law prof says
Carlyle Drops Class-Action Lawsuit Ban
Carlyle Group LP abandoned a plan to ban shareholders from filing class-action lawsuits, a proposal that could have delayed the private-equity firm’s long-awaited stock sale.